Dr. Motasem Al-Yacoub, MD

Media Releases

Get to know Neurologist Dr. Motasem Al-Yacoub, who serves patients in Pawtucket, Rhode Island.

Fluent in both English and Arabic, Dr. Al-Yacoub is a board-certified neurologist with clinical interests in general neurology, headache medicine, stroke, and dementia. He is currently serving patients at his private practice, East Bay Neurology, in Pawtucket, Rhode Island. 

The doctor is affiliated with several hospitals and medical centers in the area, including The Miriam Hospital, Landmark Medical Center, and Our Lady of Fatima Hospital. Alongside his clinical role, he serves as an Adjunct Assistant Professor of Neurology within the Department of Neurology at Brown University. 

His acclaimed career in medicine began in 1991 when he earned his medical degree from the Faculty of Medicine at Jordan University, Amman Jordan. Upon relocating to the United States, Dr. Al-Yacoub went on to complete his residency in internal medicine at Memorial Hospital of Rhode Island, followed by his residency in neurology at Brown University.

Following his training, he earned board certification in neurology by the American Board of Psychiatry and Neurology, a not-for-profit corporation dedicated to promoting high quality patient care for the public through the initial and continuing certification of psychiatrists and neurologists. He also earned board certification in internal medicine by the American Board of Internal Medicine, a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

Dr. Alyacoub is also board certified in headache medicine.

Neurology is a branch of medicine dealing with disorders of the nervous system. Neurologists are licensed medical specialists who diagnose and treat disorders that affect the brain, spinal cord, nerves, and muscles of patients. They examine a patient’s mental and physical status, conduct medical tests and scans, and evaluate the results to diagnose and treat the patient.

Recommended Articles

• Can Music Really Be A Therapy for Muscular Dystrophy?

  Ally Craig's storyThe Avant-punk group Bug Prentice has a member of the band who is very unique. He is a guitarist, singer, and songwriter in Oxford, and he also has muscular dystrophy. He uses a wheelchair and still plays the guitar. Instead of standing with his guitar strapped to his waist, Ally...

• Alzheimer's News: Analyzing the Brain to Measure Memory Decline

  New Alzheimer’s research shows declining levels of serotonin—the brain chemical linked to memory—could trigger the start of dementia. The finding from Johns Hopkins University School of Medicine opens the possibility of staying the onset of dementia and Alzheimer’s Disease by preventing the...

• Daughter Plans Wedding in Three Weeks So Mom with Alzheimer's Can Attend

  In April 2017, Stephanie got engaged to Bryan Fish. At first, their wedding was expected to take place a year after, where everything would be in place for her to have the wedding of her dreams, taking every detail into account to have something that everyone would remember. But, their plans...

• An Innovative Method for the Early Prediction of Parkinson's Disease

  As technology advances, so does the methods at the researcher’s disposal to create innovative tools that can be used in many contexts to, in one way or another, improve the user’s effectiveness at performing certain tasks. Case in point, a team of researchers from the Washington University...

• Drugs That Reduce Stickiness of Blood May Reduce Dementia by 48 Percent

  It has been long known that drugs that reduce the stickiness of blood help to keep the arteries and heart healthy and decrease the risk of cardiovascular events. Now, there is increasing evidence that these drugs may also help to reduce the incidence of dementia by as much as 48 percent.Several...

• Multiple Sclerosis and Multi-Tasking

  Trying to multitask is enough to slow down anyone. However, this twofold action poses an even greater risk to multiple sclerosis (MS) patients: the risk of cognitive impairment. The impairment can be caused by shifting from one task to two tasks, known as the dual-task cost. ...